In this webcast you will learn how next-generation IEX and HIC resins are able to address purification challenges of complex biologics, thereby improving product purity and recovery. In addition, you will see how these innovative purification solutions allow for high performance at faster flow rates, helping to increase throughput and process flexibility and ultimately realizing a more productive processes. Live: Wednesday, Dec. 4, 2019 at 8:30am IST | 11am CST | 12pm KST | 2pm AEDT On demand available after final airing Dec. 4, 2020 Register free
Register free: http://www.biopharminternational.com/bp_w/platform_purification
Event Overview:
Due to their ability to treat a wide variety of diseases, there is increased demand for biopharmaceuticals. While monoclonal antibodies (mAbs) are one of the most common biotherapeutic classes produced today, the development of other unique and challenging molecules is rapidly rising. These new therapeutic modalities present new challenges in the downstream process of these molecules. With the increased trend toward development of a 2-step chromatography process and higher protein doses, improved performance during the chromatography steps is required. Hence, process development scientists are looking for new tools that will clear even more impurities in a single step while maintaining high recoveries and process flexibility.
In this webcast, we will discuss the attributes of Thermo Scientific POROS Ion Exchange and Hydrophobic Interaction chromatography resins, addressing purification challenges of today’s biomolecules.
Key Learning Objectives:
Speakers: Orjana Terova Senior Product Manager, Bioprocessing, Thermo Fisher Scientific
Justin Qu, PhD Senior Manager, Product Specialists, Thermo Fisher Scientific
Time and Date: Wednesday, Dec. 4, 2019 at 8:30am IST | 11am CST | 12pm KST | 2pm AEDT
On demand available after final airing until Dec. 4, 2020
Sponsor: Thermo Fisher Scientific
Register free: http://www.biopharminternational.com/bp_w/platform_purification